Cellular and molecular aspects of monoamine neurotransmitter transporters

Japanese Journal of Pharmacology

Volumn 72, Issue 3, 1996, Pages 195-208

  Kitayama, Shigeo ^a   Dohi, Toshihiro ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Antidepressant; Drug abuse; Monoamine; Neurotransmitter transporter; Parkinson's disease

Indexed keywords

4 AMINOBUTYRIC ACID; CARRIER PROTEIN; DOPAMINE; MONOAMINE; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN;

CYTOLOGY; DRUG ABUSE; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; PARKINSON DISEASE; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; STRUCTURE ACTIVITY RELATION; SYNAPTIC TRANSMISSION;

EID: 0029750530     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.72.195     Document Type: Review

References (126)

1. Langer ZS and Schoemaker H: Effects of antidepressants on monoamine transporters. Prog Neuropsychopharmacol Biol Psychiat 12, 193-216 (1988)
2. Javitch AJ, D'Amato JR, Strittmatter MS and Snyder HS: Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine: Uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci USA 82, 2173-2177 (1985)
3. Snyder HS and D'Amato JR: MPTP: A neurotoxin relevant to the pathophysiology of Parkinson's disease. Neurology 36, 250-258 (1986)
4. Ritz CM, Lamb JR, Goldberg RS and Kuhar JM: Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237, 1219-1223 (1987)
5. Guastella J, Nelson N, Nelson H, Czyzyk L, Keynan S, Miedel MC, Davidson N, Lester H and Kanner B: Cloning and expression of a rat brain GABA transporter. Science 249, 1303-1306 (1990)
6. Pacholczyk T, Blakely DR and Amara GS: Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 350, 350-354 (1991)
7. Shimada S, Kitayama S, Lin C-L, Patel A, Nanthakumar E, Gregor P, Kuhar M and Uhl G: Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science 254, 576-578 (1991)
8. Kilty EJ, Lorang D and Amara GS: Clonig and expression of a cocaine-sensitive rat dopamine transporter. Science 254, 578-579 (1991)
9. Giros B, Mestikawy ES, Bertrand L and Caron GM: Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett 295, 149-154 (1991)
10. Usdin BT, Mezey E, Chen C, Brownstein JM and Huffman JB: Cloning of the cocaine-sensitive bovine dopamine transporter. Proc Natl Acad Sci USA 88, 11168-11171 (1991)
11. Huffman JB, Mezey E and Brownstein JM: Cloning of a serotonin transporter affected by antidepressants. Science 254, 579-580 (1991)
12. Blakely DR, Berson EH, Fremeau TR, Caron GM, Peek MM, Prince KH and Bradley CC: Cloning and expression of a functional serotonin transporter from rat brain. Nature 354, 66-70 (1991)
13. Liu QR, Nelson H, Mandiyan S, Lopez-Corcura B and Nelson N: Cloning and expression of a glycine transporter from mouse brain. FEBS Lett 305, 110-114 (1992)
14. Guastella J, Brecha N, Weigmann C, Lester HA and Davidson N: Cloning, expression, and localization of a rat brain high-affinity glycine transporter. Proc Natl Acad Sci USA 89, 7189-7193 (1992)
15. Smith KE, Borden LA, Hartig PR, Branchek T and Weinshank RL: Cloning and expression of a glycine transporter reveal colocalization with NMDA receptors. Neuron 8, 927-935 (1992)
16. Smith KE, Borden LA, Wang CD, Hartig PR, Branchek TA and Weinshank RL: Cloning and expression of a high affinity taurine transporter from rat brain. Mol Pharmacol 42, 563-569 (1992)
17. Liu QR, L'pez-Corcura B, Nelson H, Mandiyan S and Nelson N: Cloning and expression of a cDNA encoding the transporter of taurine and β-alanine in mouse brain. Proc Natl Acad Sci USA 89, 12145-12149 (1992)
18. --dependent taurine transporter that is regulated by hypertonicity. Proc Natl Acad Sci USA 89, 8230-8234 (1992)
19. Fremeau RT, Caron MC and Brakely RD: Molecular cloning and expression of a high-affinity L-proline transporter expressed in putative glutamatergic pathways of rat brain. Neuron 8, 915-926 (1992)
20. - -dependent betaine transporter that is regulated by hypertonicity. J Biol Chem 267, 649-652 (1992)
21. Mayser W, Schloss P and Betz H: Primary structure and functional expression of a choline transporter expressed in the rat nervous system. FEBS Lett 305, 31-36 (1992)
22. + -dependent glutamate/aspartate transporter from rat brain. Proc Natl Acad Sci USA 89, 10955-10959 (1992)
23. Pines G, Danbolt NC, Bjørås M, Zhang Y, Bendahan A, Eide L, Koepsell H, Storm-Mathisen J, Seeberg E and Kanner BI: Cloning and expression of a rat brain L-glutamate transporter. Nature 360, 464-467 (1992)
24. Kanai Y and Hediger MA: Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 360, 467-471 (1992)
25. Alfonso A, Grundahl K, Duerr JS, Han HP and Rand JB: The Caenorhabditis elegans unc-17 gene: a putative vesicular acetylcholine transporter. Science 261, 617-619 (1993)
26. + toxicity encodes a vesicular amine transporter. Cell 70, 539-551 (1992)
27. Erickson JD, Eiden LE and Hoffman BJ: Expression cloning of a reserpine-sensitive vesicular monoamine transporter. Proc Natl Acad Sci USA 89, 10993-10997 (1992)
28. Stern-Bach Y, Keen JN, Bejerano M, Steiner-Mordoch S, Wallach M, Findlay JB and Schuldiner S: Homology of a vesicular amine transporter to a gene conferring resistance to l-methyl-4-phenylpyridinium. Proc Natl Acad Sci USA 89, 9730-9733 (1995)
29. Vandenbergh JD, Persico MA and Uhl RG: A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic Taq1 RFLPs. Mol Brain Res 15, 161-166 (1992)
30. Giros B, Mestikawy S, Godinot N, Zheng K, Han H, Yang-Feng T and Caron MG: Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol Pharmacol 42, 383-390 (1992)
31. Lingen B, Bruss M and Bonisch H: Cloning and expression of the bovine sodium- and chloride-dependent noradrenaline transporter. FEBS Lett 342, 235-238 (1994)
32. Ramanoorthy S, Bauman LA, Moore RK, Han H, Yang-Feng T, Chang SA, Ganapathy V and Blakely DR: Antidepressant-and cocaine-sensitive human serotonin transporter: Molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 90, 2542-2546 (1993)
33. Lesch K-P, Wolozin LB, Estler CH, Murphy LD and Riederer P: Isolation of a cDNA encoding the human brain serotonin transporter. J Neural Transm 91, 67-72 (1993)
34. Gregor P, Patel A, Shimada S, Lin CL, Rochelle JM, Kitayama S, Seidin MF and Uhl GR: Murine serotonin transporter: sequence and localization to chromosome 11. Mamm Genome 4, 283-284 (1993)
35. Corey LJ, Quick WM, Davidson N, Lester AH and Guastella J: A cocaine-sensitive Drosophila serotonine transporter: Cloning, expression, and electrophysiological characterization. Proc Natl Acad Sci USA 91, 1188-1192 (1994)
36. Demchyshyn LL, Pristupa BZ, Sugamori SK and Barker LE: Cloning, expression, and localization of a chloride-facilitated, cocaine-sensitive serotonin transporter from Drosophila melanogaster. Proc Natl Acad Sci USA 91, 5158-5162 (1994)
37. Vandenbergh JD, Persico MA, Hawkins LA, Griffin AC, Li X, Jabs WE and Uhl RG: Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14, 1104-1106 (1992)
38. Lossie CA, Vandenbergh JD, Uhl RG and Camper AS: Localization of the dopamine transporter gene, Dat1, on mouse chromosone 13. Mamm Genome 5, 117-118 (1994)
39. Donovan MD, Vandenbergh JD, Perry PM, Bird SG, Ingersoll R, Nanthakumar E and Uhl RG: Human and mouse dopamine transporter genes: conservation of 5′-flanking sequence elements and gene structures. Mol Brain Res 30, 327-335 (1995)
40. Gelernter J, Kruger S, Pakstis JA, Pacholoczyk T, Sparkes SR, Kidd KK and Amara S: Assignment of the norepinephrine transporter protein (NET1) locus to chromosome 16. Genomics 18, 690-692 (1993)
41. Bruss M, Kunz J, Lingen B and Bonisch H: Chromosomal mapping of the human gene for the tricyclic antidepressant-sensitive noradrenaline transporter. Hum Genet 91, 278-280 (1993)
42. Lesch K-P, Balling U, Gross J, Strauss K, Wolozin LB, Murphy LD and Riederer P: Organization of the human serotonin transporter gene. J Neural Transm 95, 157-162 (1994)
43. Gelernter J, Pakstis JA and Kidd KK: Linkage mapping of serotonin transporter protein gene SLC6A4 on chromosome 17. Hum Genet 95, 677-680 (1995)
44. Nakatome M, Honda K, Islam NM, Terada M, Yamazaki M, Kuroki H, Ogura Y, Bai H and Wakasugi C: Amplication of DAT1 (human dopamine transporter gene) 3′ variable region in the Japanese population. Hum Hered 45, 262-265 (1995)
45. Muramatsu T and Higuchi S: Dopamine transporter gene polymorphism and alcoholism. Biochem Biophys Res Commun 211, 28-32 (1995)
46. Kelsoe JR, Remick RA, Sadovnick AD, Kristhjarnarson H, Flodman P, Spence MA, Morison M, Mroczkowski-Parker Z, Bergesch P, Rapaport MH, Mirow AL, Brakely RD, Helgason T and Egeland JA: Genetic linkage of bipolar disorder and serotonin transporter. Am J Med Genet 67, 215-217 (1996)
47. Shimada S, Kitayama S, Walther D and Uhl G: Dopamine trasnporter mRNA: dense expression in ventral midbrain neurons. Mol Brain Res 13, 359-362 (1992)
48. Augood JS, Westmore K, McKenna JP and Emson CP: Co-expression of dopamine transporter mRNA and tyrosin hydroxylase mRNA in ventral mesencephalic neurones. Mol Brain Res 20, 328-334 (1993)
49. Freed C, Revay R, Vaughan AR, Kriek E, Grant S, Uhl RG and Kuhar JM: Dopamine transporter immunoreactivity in rat brain. J Com Neurol 359, 340-349 (1995)
50. Ciliax JB, Heilman C, Demchyshyn LL, Pristupa BZ, Ince E, Hersch MS, Niznik BH and Levey IA: The dopamine transporter; immunochemical characterization and localization in brain. J Neurosci 15, 1714-1723 (1995)
51. Eymin C, Charnay Y, Greggio B and Bouras C: Localization of noradrenaline trasnporter mRNA expression in the human locus coeruleus. Neurosci Lett 193, 41-44 (1995)
52. Melikian EH, McDonald KJ, Gu H, Rudnick G, Moore RK and Blakely DR: Human norepinephrine transporter. J Biol Chem 269, 12290-12297 (1994)
53. Lorang D, Amara GS and Simerly BR: Cell-type-specific expression of catecholamine transporters in the rat brain. J Neurosci 14, 4903-4914 (1994)
54. Austin CM, Bradley CC, Mann JJ and Blakely DR: Expression of serotonin transporter messenger RNA in the human brain. J Neurochem 62, 2362-2367 (1994)
55. Qian Y, Melikian EH, Rye BD, Levey IA and Blakely DR: Identification and characterization of antidepressant-sensitive serotonin transporter proteins using site-specific antibodies. J Neurosci 15, 1261-1274 (1995)
56. Kimelberg HK: Occurrence and functional significance of serotonin and catecholamine uptake by astrocytes. Biochem Pharmacol 35, 2273-2281 (1986)
57. +: uptake and toxicity in nonneuronal COS cells expressing dopamine transporter cDNA. Ann Neurol 32, 109-111 (1992)
58. Pifl C, Giros B and Caron MG: Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin l-methyl-4-phenylpyridinium. J Neurosci 13, 4246-4253 (1993)
59. Gu H, Wall SC and Rudnick G: Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J Biol Chem 269, 7124-7130 (1994)
60. Strader CD, Sigal IS, Resgister RB, Candelore MR, Rands E and Dixon RAF: Identification of residues required for ligand binding to the β-adrenergic receptor. Proc Natl Acad Sci USA 84, 4384-4388 (1987)
61. Strader CD, Sigal IS, Candelore MR, Rands E, Hill WS and Dixon RAF: Conserved aspartic acid residues 79 and 113 of the β-adrenergic receptor have different roles in receptor function. J Biol Chem 263, 10267-10271 (1988)
62. Strader CD, Sigal IS and Dixon RA: Structural basis of βadrenergic receptor function. FASEB J 3, 1825-1832 (1989)
63. Kitayama S, Shimada S, Xu H, Markham L, Donovan DM and Uhl RG: Dopamine transporter site-directed mutations differently alter substrate transport and cocaine binding. Proc Natl Acad Sci USA 89, 7782 (1992)
64. + transport. Synapse 15, 58-62 (1993)
65. Buck JK and Amara GS: Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and l -methyl-4-phenylpridinium. Proc Natl Acad Sci USA 91, 12584-12588 (1994)
66. + but not dopamine through the rat dopamine transporter. Eur J Pharmacol 309, 107-109 (1996)
67. Levi G and Raiteri M: Carrier-mediated release of neurotransmitters. Trend Neurosci 16, 415-419 (1993)
68. Eshleman JA, Henningsen AR, Neve AK and Janowsky A: Release of dopamine via the human transporter. Mol Pharmacol 45, 312-316 (1994)
69. Wall CS, Gu H and Rudnick G: Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux. Mol Pharmacol 47, 544-550 (1995)
70. During JM, Ryder MK and Spencer DD: Hippocampal GABA transporter function in temporal-lobe epilepsy. Nature 376, 174-177 (1995)
71. Horton RW, Collins JF, Anlezark GM and Meldrum BS: Convulsant and anticonvulsant actions in DBA/2 mice of compounds blocking the reuptake of GABA. Eur J Pharmacol 59, 75-83 (1979)
72. Gonsalves SF, Twitchell B, Harbaugh RE, Krogsgaard-Larsen P and Schousboe A: Anticonvulsant activity of intracerebroventricularly administered glial GABA uptake inhibitors and other GABA mimetics in chemical seizure models. Epilepsy Res 4, 34-41 (1989)
73. Rudnick G and Clark J: From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. Biochim Biophys Acta 1144, 249-263 (1993)
74. Barbour B, Szatkowski M, Ingledew N and Attwell D: Arachidonic acid induces a prolonged inhibition of glutamate uptake into glial cells. Nature 342, 918-920 (1989)
75. Malchow RP and Rips H: Effect of γ-aminobutyric acid on skate retinal horizontal cells: Evidence for an electrogenic uptake mechanism. Proc Natl Acad Sci USA 87, 8945-8949 (1990)
76. Bruns D, Engert F and Lux H-D: A fast activating presynaptic reuptake current during serotonergic transmission in identified neurons of Hirudo. Neuron 10, 559-572 (1993)
77. Kavanaugh PM, Arriza LJ, North AR and Amara GS: Electrogenie uptake of γ-aminobutyric acid by a cloned transporter expressed in Xenopus oocytes. J Biol Chem 267, 22007-22009 (1992)
78. Klockner U, Storck T, Conradt M and Stoffel W: Electrogenic L-glutamate uptake in Xenopus laevis oocytes expressing a cloned rat brain L-glutamate/L-aspartate transporter (GLAST1). J Biol Chem 268, 14594-14596 (1992)
79. Mager S, Naeve J, Quick M, Labarca C, Davidson N and Lester AH: Steady states, charge movements, and rates for a cloned GABA transporter expressed in Xenopus oocytes. Neuron 10, 177-188 (1993)
80. Mager S, Min C, Henry JD, Chavkin C, Hoffman JB, Davidson N and Lester AH: Conducting states of a mammalian serotonin transporter. Neuron 12, 845-859 (1994)
81. Galli A, Deffelice JL, Duke B-J, Moore RK and Blakely DR: Sodium-dependent norepinephrine-induced currents in norepinephrine-transporter-transfected HEK-293 cells blocked by cocaine and antidepressants. J Exp Biol 198, 2197-2212 (1995)
82. Ungell AL, Oberleithner H and Graefe KH: Chloride-dependence of the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens. Naunyn Schmiedebergs Arch Pharmacol 339, 65-70 (1989)
83. Jayanthi LD, Prasad PD, Ramamoorthy S, Mahesh VB, Leibach FH and Ganapathy V: Sodium- and chloride-dependent, cocaine-sensitive, high-affinity binding of nisoxetine to the human placental norepinephrine transporter. Biochemistry 32, 12178-12185 (1993)
84. Lester HA, Mager S, Quick MW and Corey JL: Permeation properties of neurotransmitter transporters. Annu Rev Pharmacol Toxicol 34, 219-249 (1994)
85. Fairman WA, Vandenberg RJ, Arriza JL, Kavanaugh MP and Amara SG: An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature 375, 599-603 (1995)
86. Kitayama S, Morita K and Dohi T: Uptake and release of dopamine through the rat dopamine transporter expressed in Xenopus laevis oocytes. Evaluation by voltammetric measurement of intracellular doparaine concentration. Neurosci Lett 211, 132-134 (1996)
87. Giros B, Wang Y-M, Suter S, Mcleskey BS, Pifl C and Caron OM: Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J Biol Chem 269, 15985-15988 (1994)
88. Buck JK and Amara GS: Structural domains of catecholamine transporter chimeras involved in selective inhibition by antidepressants and psychomotor stimulants. Mol Pharmacol 48, 1030-1037 (1995)
89. Barker LB, Kimmel LH and Blakely DR: Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands. Mol Pharmacol 48, 799-807 (1995)
90. Vaughan AR: Photoaffinity-labeled ligand binding dopamins on dopamine transporters identified by peptide mapping. Mol Pharmacol 47, 956-964 (1995)
91. Wang JB, Davis S and Uhl GR: Dopamine transporter site-directed mutants identify residues selectively important for cocaine recognition. Soc Neurosci Abstract 19, 745 (1993)
92. Davis S, Wang JB and Uhl GR: The phenyl ring of tyrosine 250 of the dopamine transporter is required for high-affinity binding of cocaine analogs. Soc Neurosci Abstract 20, 922 (1994)
93. Kitayama S, Morita K, Dohi T, Wang JB, Davis SC and Uhl GR: Dissection of dopamine and cocaine binding sites on the rat dopamine transporter expressed in COS cells. In Cellular and Molecular Mechanisms of Drugs of Abuse: Cocaine, Ibogaine, and Substituted Amphetamines, Edited by Ali SF and Takahashi Y, Ann NY Acad Sci, The New York Academy of Science, New York (in press)
94. Lew R, Vaughan R, Simantov R, Wilson A and Kuhar JM: Dopamine transporters in the nucleus accumbens and the striatum have different apparent molecular weights. Synapse 8, 152-153 (1991)
95. Jones RS, Garris AP, Kilts DC and Wightman MR: Comparison of dopamine uptake in the basolateral amygdaloid nucleus, caudate-putamen, and nucleus accumbens of the rat. J Neurochem 64, 2581-2589 (1995)
96. Jones RS, Garris AP and Wightman MR: Different effects of cocaine and nomifensine on dopamine uptake in the caudateputamen and nucleus accumbens. J Pharmacol Exp Ther 274, 396-403 (1995)
97. --dependent serotonin transporter expressed using recombinant baculovirus in insect cells. J Biol Chem 269, 26303-26310 (1994)
98. Wang BJ, Moriwaki A and Uhl RG: Dopamine transporter cysteine muntans: Second extracellular loop cysteines are required for transporter expression. J Neurochem 64, 1416-1419 (1995)
99. Cool RD, Leibach HF, Bhalla KV, Mahesh BV and Ganapathy V: Expression and cyclic AMP-dependent regulation of a high affinity serotonin transporter in the human placental choriocarcinoma cell line (JAR). J Biol Chem 266, 15750-15757 (1991)
100. Ramamoorthy S, Cool RD, Mahesh BV, Leibach HF, Melikian EH, Blakely DR and Ganapathy V: Regulation of the human serotonin transporter. J Biol Chem 268, 21626-21631 (1993)
101. King CS, Tiller AA, Chang S-SA and Lam M-KD: Differential regulation of the imipramine-sensitive serotonin transporter by cAMP in human JAR choriocarcinoma cells, rat PC12 pheochroocytoma cells, and C33-14-B1 transgenic mouse fibroblast cells. Biochem Biophys Res Commun 183, 487-491 (1992)
102. Kadowaki K, Hirota K, Koike K, Ohmichi M, Kiyama H, Miyake A and Tanizawa O: Adenosine 3′,5′-cyclic monophosphate enhances dopamine accumulation in rat hypothalamic cell culture containing dopaminergic neurons. Neuroendocrinology 52, 256-261 (1990)
103. Annunziato L, Leblanc P, Kordon C and Weiner RI: Differences in the kinetics of dopamine uptake in synaptosome preparations of the median eminence relative to other dopaminergically innervated brain regions. Neuroendocrinology 31, 316-320 (1980)
104. Tian Y, Kapatos G, Granneman GJ and Bannon JM: Dopamine and γ-aminobutyric acid transporters: differential regulation by agents that promote phosphorylation. Neurosci Lett 173, 143-146 (1994)
105. Anderson MG and Home CW: Activators of protein kinase C decrease serotonin trasnport in human platelets. Biochim Biophys Acta 1137, 331-337 (1992)
106. Myers LC, Lazo SJ and Pitt RB: Translocation of protein kinase C is associated with inhibition of 5-HT uptake by cultured endothelial cells. Am J Physiol 257, L253-L258 (1989)
107. Kitayama S, Dohi T and Uhl RG: Phorbol esters alter functions of the expressed dopamine transporter. Eur J Pharmacol 268, 115-119 (1994)
108. Corey LJ, Davidson N, Lester AH, Brecha N and Quick WM: Protein kinase C modulates the activity of a cloned γ-aminobutyric acid transporter expressed in xenopus oocytes via regulated subcellular redistribution of the transporter. J Biol Chem 269, 14759-14767 (1994)
109. Jayanthi DL, Ramamoorthy S, Mahesh BV, Leibach HF and Ganapathy V: Calmodulin-dependent regulation of the catalytic function of the human serotonin transporter in placental choriocarcinoma cells. J Biol Chem 269, 14424-14429 (1994)
110. 3H]dopamine uptake in rat striatum: Possible involvement of calmodulin-dependent kinases. J Neurochem 65, 2065-2071 (1995)
111. Nishio H, Nezasa K and Nakata Y: Role of calcium ion in platelet serotonin uptake regulation. Eur J Pharmacol 288, 149-155 (1995)
112. Casado M, Bendahan A, Zafra F, Danbolt CN, Aragon C, Giménez C and Kanner IB: Phosphorylation and modulation of brain glutamate transporters by protein kinase C. J Biol Chem 268, 27313-27317 (1993)
113. 3 receptors regulate serotonine transport via nitric oxide and cGMP. J Biol Chem 269, 27351-27356 (1994)
114. Yamashita H, Kitayama S, Zhang Y-X, Takahashi T, Dohi T and Nakamura S: Effect of nicotine on dopamine uptake in COS cells possessing the rat dopamine transporter and in PC 12 cells. Biochem Pharmacol 49, 742-745 (1995)
115. Lesch PK, Aulakh SC, Wolozin LB, Tolliver JT, Hill LJ and Murphy LD: Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants. Mol Brain Res 17, 31-35 (1993)
116. Kuroda Y, Watanabe Y and McEwen SB: Tianeptine decreases both serotonin transporter mRNA and binding sites in rat brain. Eur J Pharmacol 268, R3-R5 (1994)
117. Szot P, Ashliegh EA, Kohen R, Dorsa DM and Veith R: Norepinephrine transporter mRNA is elevated in the locus coeruleus following short- and long-term desipramine treatment. Brain Res 618, 308-312 (1993)
118. Shores MM, Szot P and Veith CR: Desipramine-induced increase in norepinephrine transporter mRNA is not mediated via α2 receptors. Mol Brain Res 27, 337-341 (1992)
119. Kuhar MJ, Ritz MC and Boja JW: The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14, 299-302 (1991)
120. 3H]dopamine uptake in vitro in rat nucleus accumbens but not in striatum. Brain Res 531, 338 - 341 (1990)
121. Pilotte NS, Sharpe LG and Kuhar MJ: Withdrawal of repeated intravenous infusions of cocaine persistently reduces binding to dopamine transporters in the nucleus accumbens of Lewis rats. J Pharmacol Expr Ther 269, 963-969 (1994)
122. Xia Y, Goebel JD, Kapatos G and Bannon JM: Quantitation of rat dopamine transporter mRNA: Effects of cocaine treatment and withdrawal. J Neurochem 59, 1179-1182 (1992)
123. Cerruti C, Pilotte SN, Uhl G and Kuhar JM: Reduction in dopamine transporter mRNA after cessation of repeated cocaine administration. Mol Brain Res 22, 132-138 (1992)
124. Lu D, Yu K, Paddy RM, Rowland EN and Raizada KM: Regulation of norepinephrine transport system by angiotensin 2 in neuronal cultures of normotensive and spontaneously hypertensive rat brains. Endocrinology 137, 763-772 (1996)
125. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanal Y, Hediger MA, Wang Y, Schielke JP and Welty DF: Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16, 675-686 (1996)
126. Giros B, Jaber M, Jones SR, Wightman RM and Caron MG: Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612 (1996)